NCT00567983已完成4 期
Topical Cyclosporine and Disease Progression
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Disease Severity
研究概览
简要总结
The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Mild to Moderate dry eye symptoms
排除标准
- •Current use of Restasis
研究组 & 干预措施
1.
Active Comparator
干预措施: Restasis (Drug)
2.
Placebo Comparator
干预措施: Endura (Drug)
结局指标
主要结局
Disease Severity
时间窗: 1 yr
次要结局
- Staining(1 yr)
研究者
研究点 (1)
Loading locations...
相似试验
终止
4 期
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry EyeDry EyeNCT00553735Massachusetts Eye and Ear Infirmary8
已完成
4 期
Efficacy of Topical Cyclosporin for Ocular RosaceaRosaceaNCT00348335Ophthalmic Consultants of Long Island35
招募中
3 期
The effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19IRCT20200426047206N3Hamedan University of Medical Sciences48
终止
不适用
The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular SurfaceDry EyeNCT02199964Baylor College of Medicine4
已完成
4 期
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseasePrimary Sjogren SyndromeSecondary Sjogren SyndromeAqueous Deficient Dry Eye DiseaseEvaporative Dry Eye DiseaseNCT02004067Federal University of São Paulo100